Planet 13 Revenue Soars 63% as Las Vegas Takes Off
Ryan Allway December 21st, 2018 News, Top News The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of recreational cannabis across a growing number of states. Since legalizing recreational cannabis at the beginning of the year, Nevada—and... Read more
Weekend Unlimited Inc. Announces Appointment of President & CEO
Tony Deyes December 21st, 2018 News, Top News As the emerging cannabis industry continues to evolve key personnel hirings become increasingly crucial to a company’s success; cannabis lifestyle brand Weekend Unlimited, Inc. (CSE: YOLO) has made such a move. The company recently announced the appointment of Paul Chu,... Read more
International Cannabis Corp. Bolstering European Supply Chain
Tony Deyes December 21st, 2018 News, Top News Europe’s population is twice the size of the US & Canada combined, but it’s cannabis market is still in its infancy compared to North America’s. North American companies operating in more mature markets are currently scrambling to get their products... Read more
Aleafia-Emblem Merger Creates Canada’s Largest Network of Clinics
Ryan Allway December 20th, 2018 Uncategorized Canada’s cannabis industry may be rapidly growing with new initial public offerings each week, but there has also been a fair share of consolidation within the industry. Investors may want to take a closer look at industry mergers, since they have the... Read more
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
Ryan Allway December 20th, 2018 – 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic– Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced... Read more
Cardiol Therapeutics (TSX:CRDL) Goes Public on the Toronto Stock Exchange, Focused on Pharmaceutical CBD and Biotech Science
Robin Lefferts December 20th, 2018 Exclusive, News, Top News After decades of limitations on scientific study of cannabis, new regulatory environments are starting to allow science to catch up with the widely recognized therapeutic potential of the plant. To date, the U.S. Food and Drug Administration has approved... Read more
High Hampton’s Mojave Jane Announces Start Of Production In California January 2019
“While Mojave Jane’s production delivers revenue and cash flow to the Company, it also means realizing the advantages of integrating with High Hampton’s complete portfolio”, commented Gary Latham, High Hampton’s CEO. “That is where the real long term value of this company will be realized.” About Mojave Jane LLC.... Read more
Creso Pharma Brings Together Cannabis Experts Across Several Verticals
Ryan Allway December 18th, 2018 Exclusive, Top News The due diligence process looks very different for small-cap versus large-cap stocks. When analyzing large-cap companies, investors pay closest attention to financial statements and valuation ratios to extrapolate growth rates and apply multiples. Small-cap stocks tend to be earlier stage... Read more
3 Sixty Secure: A Premier Opportunity in Cannabis Security
Ryan Allway December 18th, 2018 Exclusive, Top Story The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a 34.6 percent compound annual growth rate. After legalizing cannabis on a federal level in October, Canada has become a world leader... Read more
Wiz Khalifa Partners with Supreme to Expand Cannabis Brand
Ryan Allway December 18th, 2018 Exclusive, News, Press Releases, Top News The music industry has become increasingly intertwined with the cannabis industry over the past several years. With the partnership between Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Snoop Dogg in 2016, these relationships grew even closer... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )